Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mike, Foresti"'
Autor:
Elke Boxhammer, Meriem Bellamine, Istvan Szendey, Mike Foresti, Marc Bonsels, Joseph Kletzer, Peter Jirak, Albert Topf, Johannes Kraus, Lukas Fiedler, Anna-Maria Dieplinger, Uta C. Hoppe, Bernhard Strohmer, Lars Eckardt, Rudin Pistulli, Lukas J. Motloch, Robert Larbig
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionWhile in the CASTLE-AF trial, in patients with atrial fibrillation and heart failure with reduced ejection fraction, interventional therapy using pulmonary vein isolation was associated with outcome improvement, data on cavotricuspid isth
Externí odkaz:
https://doaj.org/article/e7c1f4a8bec74a46864e783660c1dc2f
Autor:
Lluis Asmarats, Josep Rodés-Cabau, Gilles O'Hara, Robert Sabiniewicz, Mike Foresti, Adolphe Kasongo, Serban Puricel, Jean-Bernard Masson, Paolo Pagnotta, Diego Maffeo, Giuseppe Tarantini, Stéphane Cook, Francesco Pisano, Ignacio Cruz-González, Julio Carballo, Reda Ibrahim, Adam Sukiennik, Carmelo Grasso, Jose Carlos Moreno-Samos, Mauro Chiarito, Gaetano Senatore, Nathan Messas
Publikováno v:
JACC: Cardiovascular Interventions. 11:1932-1941
Objectives This study sought to evaluate the feasibility, safety, and efficacy of the Ultraseal device for left atrial appendage closure (LAAC) (Cardia, Eagan, Minnesota) in patients with nonvalvular atrial fibrillation at high bleeding risk. Backgro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::758e1d9a68ccf5b9cb24566f1f9caf33
https://doi.org/10.1016/j.jcin.2018.05.023
https://doi.org/10.1016/j.jcin.2018.05.023
Autor:
Lluis, Asmarats, Jean-Bernard, Masson, Paolo A, Pagnotta, Stéphane, Cook, Mike, Foresti, Réda, Ibrahim, Adam, Sukiennik, Robert, Sabiniewicz, Diego, Maffeo, Julio, Carballo, Ignacio, Cruz-González, Carmelo, Grasso, Francesco, Pisano, Gaetano, Senatore, Giuseppe, Tarantini, Adolphe, Kasongo, Mauro, Chiarito, Serban, Puricel, Nathan, Messas, Jose Carlos, Moreno-Samos, Gilles, O'Hara, Josep, Rodés-Cabau
This study sought to evaluate the feasibility, safety, and efficacy of the Ultraseal device for left atrial appendage closure (LAAC) (Cardia, Eagan, Minnesota) in patients with nonvalvular atrial fibrillation at high bleeding risk.The Ultraseal devic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eafabecb07017a0cb4ec971a57b67bcf
http://hdl.handle.net/11577/3279357
http://hdl.handle.net/11577/3279357
Autor:
Lluis Asmarats, Josep Rodés-Cabau, Adam Sukiennik, Gilles O'Hara, Carmelo Grasso, Paolo Pagnotta, Adolphe Kasongo Mukombola, Jean-Bernard Masson, Mauro Chiarito, Stéphane Cook, Robert Sabiniewicz, Nathan Messas, Jose Carlos Moreno Samos, Reda Ibrahim, Giuseppe Tarantini, Gaetano Senatore, Mike Foresti, Ignacio Cruz-González
Publikováno v:
Journal of the American College of Cardiology. 72:B45
The Ultraseal device (Cardia Inc., Eagan, MN) is a new left atrial appendage closure (LAAC) device, with a distal bulb and a proximal sail, connected by an articulating joint. We evaluated the feasibility, safety and efficacy of the Ultraseal device
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8379bde9f55c46c314f3bb75d905a3d1
https://doi.org/10.1016/j.jacc.2018.08.1202
https://doi.org/10.1016/j.jacc.2018.08.1202
Autor:
Wolfgang Schaper, Ernst R. Schwarz, Mike Foresti, Margarete Arras, Jan Fleischhauer, Masahiro Mohri, Holger Montino, Thorsten Schuetz, Stefan Sack, Raj Chakupurakal, Peter Hanrath
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 3:63-70
Background: Controversy exists concerning the duration of infarct size reduction with ischemic preconditioning in different species. In the present study, we (a) evaluated the time course of protection with preconditioning and (b) sought to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a287b4036040c40ccaa8e8ccd62e2d2a
https://doi.org/10.1177/107424849800300108
https://doi.org/10.1177/107424849800300108